Predictice ADMET studies, the challenges and the opportunities

被引:74
作者
Davis, AM [1 ]
Riley, RJ [1 ]
机构
[1] AstraZeneca R&D, Dept Phys & Metab Sci, Loughborough LE11 5RH, Leics, England
关键词
D O I
10.1016/j.cbpa.2004.06.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Predictive ADMET is the new 'hip' area in drug discovery. The aim is to use large databases of ADMET data associated with structures to build computational models that link structural changes with changes in response, from which compounds with improved properties can be designed and predicted. These databases also provide the means to enable predictions of human ADMET properties to be made from human in vitro and animal in vivo ADMET measurements. Both methods are limited by the amount of data available to build such predictive models, the limitations of modelling methods and our understanding of the systems we wish to model. The current failures, successes and opportunities are reviewed.
引用
收藏
页码:378 / 386
页数:9
相关论文
共 54 条
[1]   Competitive CYP2C9 inhibitors:: Enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis [J].
Afzelius, L ;
Zamora, I ;
Ridderström, M ;
Andersson, TB ;
Karlén, A ;
Masimirembwa, CM .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :909-919
[2]  
Black DJ, 1996, DRUG METAB DISPOS, V24, P422
[3]  
Bonnabry P, 2001, INTERINDIVIDUAL VARIABILITY IN HUMAN DRUG METABOLISM, P240
[4]   Search for predictive generic model of aqueous solubility using Bayesian neural nets [J].
Bruneau, P .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (06) :1605-1616
[5]   Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats [J].
Chiou, WL ;
Barve, A .
PHARMACEUTICAL RESEARCH, 1998, 15 (11) :1792-1795
[6]   Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans [J].
Chiou, WL ;
Jeong, HY ;
Chung, SM ;
Wu, TC .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :135-140
[7]   Comparison of oral absorption and bioavailability of drugs between monkey and human [J].
Chiou, WL ;
Buehler, PW .
PHARMACEUTICAL RESEARCH, 2002, 19 (06) :868-874
[8]   Application and limitations of X-ray crystallographic data in structure-based ligand and drug design [J].
Davis, AM ;
Teague, SJ ;
Kleywegt, GJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (24) :2718-2736
[9]   Pharmacophore modeling of cytochromes P450 [J].
de Groot, MJ ;
Ekins, S .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) :367-383
[10]   Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates [J].
Ekins, S ;
Kim, RB ;
Leake, BF ;
Dantzig, AH ;
Schuetz, EG ;
Lan, LB ;
Yasuda, K ;
Shepard, RL ;
Winter, MA ;
Schuetz, JD ;
Wikel, JH ;
Wrighton, SA .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :974-981